Target intelligence / Profile preview

Small Cajal body-specific RNA 13 (SCARNA13)

Target
SCARNA13
Molecular classification
Non-coding RNA, Small Cajal body-specific RNA (scaRNA), H/ACA box snoRNA
01

Overview

Small Cajal body-specific RNA 13 (SCARNA13, also known as U93) is a non-coding RNA of the scaRNA family that localizes to the Cajal bodies, a nuclear subcompartment involved in the maturation of small nuclear ribonucleoproteins (snRNPs). SCARNA13 is classified as an H/ACA box snoRNA, meaning it forms a complex with proteins such as dyskerin and guides pseudouridylation, a specific RNA modification, likely targeting spliceosomal snRNAs. Its main function is thought to be the modification of RNA molecules involved in pre-mRNA splicing, helping regulate gene expression and RNA maturation. SCARNA13 has no established direct drug interactions and is not recognized as a therapeutic target but may play a role in diseases, particularly certain cancers.

Other names
U93SCARNA13
02

Biological functions

RNA processingPost-transcriptional modification of spliceosomal snRNAs (such as pseudouridylation)
03

Disease associations

Cancer (notably associated in some studies with glioma susceptibility and spleen angiosarcoma)

Beyond the preview

Go deeper on Small Cajal body-specific RNA 13 (SCARNA13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small Cajal body-specific RNA 13 (SCARNA13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call